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Abstract
Background: The phylum Apicomplexa includes intracellular parasites causing immense global disease burden, the
deadliest of them being the human malaria parasite Plasmodium falciparum, which invades and replicates within
erythrocytes. The cytoskeletal protein actin is well conserved within apicomplexans but divergent from mammalian actins,
and was primarily reported to function during host cell invasion. However, novel invasion mechanisms have been described
for several apicomplexans, and specific functions of the acto-myosin system are being reinvestigated. Of the two actin
genes in P. falciparum, actin-1 (pfact1) is ubiquitously expressed in all life-cycle stages and is thought to be required for
erythrocyte invasion, although its functions during parasite development are unknown, and definitive in vivo
characterisation during invasion is lacking.
Results: Here we have used a conditional Cre-lox system to investigate the functions of PfACT1 during P. falciparum blood-
stage development and host cell invasion. We demonstrate that PfACT1 is crucially required for segregation of the plastid-like
organelle, the apicoplast, and for efficient daughter cell separation during the final stages of cytokinesis. Surprisingly, we observe
that egress from the host cell is not an actin-dependent process. Finally, we show that parasites lacking PfACT1 are capable of
microneme secretion, attachment and formation of a junction with the erythrocyte, but are incapable of host cell invasion.
Conclusions: This study provides important mechanistic insights into the definitive essential functions of PfACT1 in
P. falciparum, which are not only of biological interest, but owing to functional divergence from mammalian actins,
could also form the basis for the development of novel therapeutics against apicomplexans.
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Background
The phylum Apicomplexa includes many important human
pathogens against which no effective vaccines exist and the
number of usable drugs remains scarce. Of note are Plasmo-
dium, the aetiological agent of malaria, and Toxoplasma
gondii, an opportunistic pathogen that leads to fatal disease
in immunocompromised patients [1]. Malaria causes almost
half a million deaths and immeasurable morbidity every year,
with most deaths attributable to Plasmodium falciparum,
the deadliest of the five parasite species capable of infecting
humans [2]. The clinical manifestations of malaria are
caused by the asexually reproducing haploid blood stages,
which invade erythrocytes and establish themselves within a
parasitophorous vacuole (PV) within the host cell. Post-
invasion, the intraerythrocytic ring stages grow into
trophozoites, which divide their nuclei asynchronously by
schizogony to form a multinucleated schizont. The mature
schizont undergoes a tightly regulated mechanism of egress
to break open the PV and the host cell membranes and release
daughter merozoites, thus completing a 48-h asexual cycle.
Actin is a central component of the eukaryotic
cytoskeleton; actin polymerisation and depolymerisation
together with cargo-carrying myosins ‘walking’ on poly-
merised actin tracks form the basis for many cellular func-
tions such as locomotion, cell shape maintenance, vesicular
trafficking, gene regulation, cell division and a plethora of
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other processes [3, 4]. Apicomplexans share a conserved
acto-myosin system, although species-specific differences
exist in the repertoire of myosins [5]. The role of the acto-
myosin system during the intracellular development of api-
complexan parasites is largely unknown. However, recent
studies in T. gondii demonstrated a role for the system in
maintenance of the plastid-like organelle, the apicoplast, in
dense granule motility and in material transport between in-
dividual parasites within a parasitophorous vacuole [6–10].
Similarly, in Plasmodium spp. intracellular functions of actin
have been suggested, such as during endocytosis [11], secre-
tion [12] and antigenic variation [13, 14].
To date, studies on apicomplexan actin have focussed
mainly on its suggested central role during parasite motility
and host cell invasion: According to the prevalent view,
short, highly dynamic actin filaments are formed between
the plasma membrane and the inner membrane complex
(IMC) of the parasite and are used as tracks by the MyoA
motor complex to generate force during these processes
[15]. The MyoA motor complex consists of the myosin
light chain 1 (MLC1) and gliding associated proteins
(GAPs) that anchor this complex between the IMC and the
plasma membrane, although, as recently highlighted, the
exact organisation of this motor and its role during host cell
invasion are still a matter of debate [16, 17]. Most of our
understanding of the molecular players during invasion by
apicomplexan parasites, in particular the role of actin,
comes from research on Toxoplasma gondii and Plasmo-
dium spp. [18, 19]. According to the current model, surface
ligands derived from micronemes are indirectly linked to
the actin cytoskeleton and thereby act as force transmitters
that are relocated to the posterior of the parasite by the
action of the MyoA motor complex. These ligands are
subsequently shed by the action of subtilisin-like and
rhomboid proteases to release the tight interaction with the
substrate [20–23]. Intriguingly, recent reverse genetic
studies in T. gondii and Plasmodium led to the re-
evaluation of several components previously assumed to be
crucial for motility and invasion, such as rhomboid
proteases, which were believed to be essential for shedding
[22, 24], and surface ligands such as merozoite surface
protein 1 (MSP1) [25], apical membrane antigen 1 (AMA1)
[26] and merozoite TRAP-like protein (MTRAP) [27, 28],
which were believed to act as attachment factors or force
transmitters. In the case of Toxoplasma, the acto-myosin
system itself could be fully depleted without completely ab-
rogating gliding motility or invasion, necessitating formula-
tion of new and updated models for these processes [29]. A
recent study convincingly demonstrated that membrane
dynamics at the entry point, regulated by host cell actin,
leads to engulfment of Toxoplasma in the absence of MyoA
[30]. Whilst similar kinetic models have been proposed for
Plasmodium merozoite invasion into erythrocytes [31, 32],
the contribution of host versus parasite actin during
erythrocyte invasion is still unclear. Currently the functional
characterisation of P. falciparum actin relies on inhibitors
for F-actin depolymerisation and polymerisation, such as
jasplakinolide, latrunculins and cytochalasins [18]. Recent
studies, however, question the specificity of inhibitors for
apicomplexan actins [29] and demonstrated that latruncu-
lins are not effective against Toxoplasma [29] or Plasmo-
dium actin [33]. In the case of the widely used inhibitor
cytochalasin D, off-target effects have been reported in
Toxoplasma [19, 29].
Therefore, a reverse genetic functional analysis of P.
falciparum actin is required to analyse and validate the
functions of the protein in detail and to compare it to the
diverse functions found in other apicomplexans. Of particu-
lar interest in terms of host cell invasion is the question if,
similar to Toxoplasma gondii, parasite uptake can be
facilitated by the host cell once the acto-myosin system of
the parasite is completely inactivated [29, 30].
The P. falciparum genome encodes two actin genes [34],
actin-1 (pfact1) and actin-2 (pfact2), with PfACT1
expressed ubiquitously throughout all life-cycle stages, and
PfACT2 confined to the mosquito stages and transmittable
sexual stages [35]. Like canonical actins, PfACT2 can form
long filaments, and disruption of the gene abrogated exfla-
gellation of male gametocytes [35, 36]. In contrast, pfact1
has thus far not been disrupted by molecular genetic
approaches [36], and hence a classical reverse genetic
analysis of PfACT1 function has not been possible. In vitro
studies have shown that PfACT1 is only capable of
forming short filaments [37, 38] and is thought to be the
actin responsible for active invasion by merozoites,
although definitive in vivo characterisation is lacking.
Moreover, the functions of actin dynamics during blood-
stage P. falciparum development are largely unknown,
despite the fact that PfACT1 mRNA is highly upregulated
from the onset of nuclear division (http://plasmodb.org/
plasmo/app/record/gene/PF3D7_1246200#transcriptomics),
indicating functions for the protein during parasite
maturation.
Here we used a dimerisable Cre (DiCre)-based genetic sys-
tem [39] to conditionally disrupt pfact1 and determine the
functions of the protein during intracellular development and
host cell invasion. Importantly, our study highlights functional
conservation and unique differences between Toxoplasma
and Plasmodium actin and demonstrates that, in contrast to
Toxoplasma, Plasmodium critically depends on PfACT1 to
invade the host cell, indicating that in this case no parasite
uptake can occur via host cell-dependent pathways.
Results
Conditional disruption of PfACT1 kills parasites within
one replication cycle
We used a DiCre-mediated conditional gene deletion
technique [8, 39] to target pfact1 (Fig. 1a) in P. falciparum.
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In order to not disrupt native actin function, we avoided
the use of any epitope tag and employed the strategy of
introducing a loxP site within a heterologous intron (lox-
Pint) in the middle of the pfact1 gene. Additional loxP
sites were introduced at the 3´ end of the gene. This
approach was previously shown to have no adverse impact
on protein expression or function, since the loxPint
module is efficiently spliced [25, 40]. Furthermore, the
promoter region is unaffected by this approach, leading to
correct timing of gene expression. The construct pHH1-
pfact1loxPint, containing a modified pfact1 genetic se-
quence with intervening and flanking loxP sites, was trans-
fected into the DiCre expressor strain 1G5DiCre [39].
Upon integration into the parasite genome, a line (lox-
PACT1) was produced in which the C-terminal part of
PfACT1 could be efficiently excised upon activation of
DiCre with rapamycin (RAP). This effectively resulted in a
null mutant, since the 192 amino acid residues in the C-
Fig. 1 Strategy for modification and conditional disruption of pfact1. a Schematic showing single crossover allelic replacement of the endogenous
pfact1 gene in the P. falciparum 1G5DiCre line with the construct pHH1-pfact1loxPint, which includes a 493-bp homologous targeting region (target)
followed by the loxPint module (yellow) followed by a recodonised pfact1 sequence (syn), coding for the rest of the pfact1 open reading frame.
LoxP sites are depicted as black triangles. Integration replaced the pfact1 3´ UTR with that of P. berghei dihydrofolate reductase gene (pbdt). The hdhfr
cassette confers resistance to the drug WR99210. Following RAP-induced recombination between loxP sites, the 3´ half of the pfact1 gene, coding
for the C-terminal 192 aa residues, was removed along with the introduction of STOP codons. Positions of hybridisation of primers for diagnostic
polymerase chain reaction (PCR) have been depicted as red, blue and black half arrows. b Time course of diagnostic PCR with primers showing loss of
the integrant pfact1 locus 18, 34 and 44 h post-RAP treatment (Int, red half arrows and red arrow heads), with a concomitant appearance of the excised
locus (Exc, black half arrows and white arrow heads) and no reduction in product of the control PCR (Con, blue half arrows). The asterisk (*) marks an
intermediate product of excision which is rapidly lost by 34 h. c Western blot showing reactivity to a PfACT1 antibody raised against residues 239 to
253 (Actin) is lost within 44 h post-RAP-induced excision; anti-AMA1 staining is used as control. See also Additional file 1: Figure S1b d IFA shows a
loss of reactivity of PfACT1 KOs to the anti-PfACT1 antibody. The PV is depicted in red (Sera-5). Scale bar 5 μm. See also Additional file 2: Figure S2.
e Parasitaemia counts indicate an abrupt death of PfACT1 KO parasites (RAP) in the following asexual cycle (day 3). N > 1000. Error bars represent
standard deviation (SD)
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terminal half of the protein are required for actin polymer-
isation [35]. Two independent clones, B2 and F4, were
obtained and used for phenotypic characterisation. In-
duction of DiCre with pulse treatment of RAP for 4 h
in 1 h post-invasion ring stages (Additional file 1: Fig-
ure S1a, RAP (at 1 h)) resulted in robust and efficient
excision of the target pfact1 locus (Fig. 1b). The intact
locus was excised to completion between 18 and 34 h
in the RAP-treated population (Fig. 1b, red arrow
heads), with protein levels dropping to 13% by 34 h and
to <7% by 44 h (Additional file 1: Figure S1b and 1c).
PfACT1 disruption was apparent by immunofluores-
cence assay (IFA) in schizonts 44 h post-induction
(Fig. 1d and Additional file 2: Figure S2). Based on IFAs
(Additional file 2: Figure S2), it was estimated that
~98% of the population had undergone excision of
pfact1, resulting in an almost pure population of pfact1
disrupted parasites (PfACT1 KO) for phenotypic ana-
lysis. Only a weak, potentially non-specific signal could
be detected by IFA in PfACT1 KO schizonts (Fig. 1d,
Additional file 2: Figure S2). We further noted that
PfACT1 protein expression in dimethyl sulfoxide
(DMSO) controls increased about threefold between 34 h
and 44 h as compared to aldolase expression (Additional file
1: Figure S1b), consistent with increased mRNA levels at the
late trophozoite stages (http://plasmodb.org/plasmo/app/
record/gene/PF3D7_1246200#transcriptomics), indicating
functional importance during these stages.
As expected, PfACT1 KOs could not be sustained in
culture, formally demonstrating that PfACT1 is indis-
pensable for P. falciparum viability (Fig. 1e). No discern-
ible phenotype was observed in Giemsa-stained
trophozoite stages (Additional file 1: Figure S1, 26 h,
38 h), but parasites were absent in the following replica-
tion cycle (Fig. 1e) with uninvaded merozoites apparent
in thin blood films at 48 h post-RAP treatment
(Additional file 1: Figure S1, 48 h), implying defects
either in mature schizont development, in egress, in
erythrocyte invasion or in a combination of these.
Interestingly, when excision of PfACT1 was induced by
RAP 30 h post-invasion (instead of 1 h post-invasion),
the phenotype was consistently apparent at 48 h in the
same replication cycle (Additional file 1: Figure S1, RAP
(at 30 h)). However, when RAP was added 44 h post-
invasion, parasites invaded normally in the same replica-
tion cycle but displayed abrogated invasion at the end of
the next replication cycle (Additional file 1: Figure S1,
RAP (at 44 h)).
PfACT1 is required for apicoplast segregation and
merozoite development
Maintenance of cellular organelles requires actin in
many eukaryotic systems. To identify the role of PfACT1
in organelle biogenesis during intracellular development
of the parasite, IFAs on mature segmented schizonts
using different organellar markers were performed. No
differences in the localisation or structure of the unique
secretory organelles in PfACT1 KOs were apparent upon
immunostaining (Fig. 2a, top 2 panels). Furthermore,
mitochondria architecture in PfACT1 KOs also
remained indistinguishable from DMSO controls (Fig. 2a,
bottom panel). Strikingly, however, RAP-treated para-
sites contained a collapsed mass of aberrant apico-
plast(s), which presumably had failed to migrate to
individual daughter cells (Fig. 2b, white arrow and
Additional file 2: Figure S2). In contrast, DMSO controls
showed apicoplast staining in each of the daughter
merozoites (Fig. 2b and Additional file 2: Figure S2). In
order to further investigate apicoplast migration dynam-
ics, we examined apicoplast architecture as a function of
time (Fig. 2c). As previously described [41], the apico-
plast stained as a simple structure in immature stages
(Fig. 2c, DMSO, 20 h) which became complex and retic-
ulated with time (Fig. 2c, DMSO, 40 and 44 h). In
mature schizont stages, the apicoplast segregated into
individual daughter cells (Fig. 2c, DMSO, 44 h). In
contrast, the apicoplast in the PfACT1 KOs showed few
branches and eventually collapsed close to the food
vacuole (FV) (Fig. 2c, RAP), indicating that apicoplast
migration requires actin filaments. At 44 h, >90% of the
RAP-treated population showed collapsed apicoplasts
(Fig. 2d and Additional file 2: Figure S2). Indeed
co-staining with an anti-PfACT1 antibody that
preferentially recognises F-actin [42] demonstrated that
filamentous F-actin structures connect individual apico-
plasts (Fig. 2c, white arrows), which was confirmed by
super-resolution microscopy (Fig. 2c, bottom panel). In
contrast, similar filaments were never observed in
PfACT1 KO parasites, demonstrating specificity of this
antibody, as described previously [42]. Together, these
results suggest a conserved function of Plasmodium and
Toxoplasma actin-1 [8] in apicoplast segregation.
In order to be eventually passed on from an infected
host to a naïve individual, malaria parasites differentiate
into male and female gametocytes which are taken up dur-
ing a blood meal by the female Anopheles mosquito. These
sexual stages represent a bottleneck in the malaria life
cycle, and the development of gametocidal agents holds
great promise to combat the spread of the disease [43].
Newly invaded ring stages which will develop into male
and female gametocytes are already committed to sexual
development in the previous asexual cycle [44]. RAP treat-
ment of newly invaded ring stages in the loxPACT1 clones
thus removes the ability of already committed gameto-
cytes to further express PfACT1. We observed that the
numbers of gametocytes that persisted 44 h after RAP
treatment were comparable to those in the DMSO
controls (Additional file 3: Figure S3), indicating that
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gametocyte survival, at least within the first 48 h, is not re-
liant on de novo expression of PfACT1. Whether these ga-
metocytes will continue developing into more mature
forms is beyond the scope of this manuscript and will be
the subject of an independent study.
Next, we investigated the role of PfACT1 in daughter
cell formation during schizont development. We ob-
served no gross defects in schizont cellular morphology
in PfACT1 KO schizonts (Fig. 3a, brightfield). However,
aberrant surface staining was observed in RAP-treated
schizonts using an anti-MSP1 antibody (Fig. 3a), where
the daughter merozoites appeared disorganised and sev-
eral daughters, particularly in medial regions of the
schizont, appeared dysmorphic (Fig. 3a, white arrow).
We scored PfACT1 KO schizonts showing normal, mod-
erately aberrant and severely aberrant MSP1 staining
(Fig. 3a, m.a. and s.a.). Whilst 86% of DMSO controls
showed normal MSP1 staining, 49% of PfACT1 KOs
showed moderately aberrant and 23% showed severely
aberrant MSP1 staining (Fig. 3a, right panel). Similar
results were obtained when we stained for the IMC with
an anti-glideosome-associated protein 45 (GAP45) anti-
body (Additional file 4: Figure S4). In order to further
investigate this defect in schizont morphology, we
performed transmission electron microscopy (TEM) on
PfACT1 KO mature schizonts, cultured for an additional
4–6 h in the presence of the protein kinase G inhibitor
Compound 1 (C1), ensuring full development into
segmented schizonts, as previously described [45]. In
DMSO controls, the boundaries between the daughter
merozoite plasma membrane and the FV membrane
were well defined (Fig. 3b, DMSO, double black ar-
rows), indicating complete cell separation following
segmentation. Surprisingly, RAP-treated parasites showed
Fig. 2 PfACT1 is not required for secretory organelle formation but is crucial for apicoplast segregation. a RAP-treated PfACT1 KO parasites have similar
microneme (anti-AMA1), rhoptry (anti-RhopH2) and mitochondria (mito; anti-TOM40) architecture as DMSO controls, as revealed by IFA. b The apicoplast
in PfACT1 KO parasites fails to segregate to daughter merozoites and collapses to an amorphous mass close to the food vacuole (white arrow). c IFA of
samples drawn at various time points shows that apicoplast reticulation and division increase with nuclear division (DMSO, 20, 40, 44 h). The apicoplast
shows close apposition to F-actin staining (zoom, white arrows). Actin staining disappears within 40 h of RAP treatment. The apicoplast does not show
reticulation and extensive migration in the absence of PfACT1 (RAP, 40 and 44 h). Scale bar 5 μm. Bottom panel: Super-resolution imaging reveals close
apposition of apicoplasts on the actin network. Enlarged inset in ‘merge’ shows apicoplast colocalised to actin filament (white arrows). Colocalisation
analysis of apicoplast on actin in the entire image yielded a Manders coefficient of 0.83. d Quantification of schizonts showing completely segregated,
collapsed or intermediate apicoplasts in DMSO- or RAP-treated populations. N > 300. Error bars represent SD. See also Additional file 1: Figure S1
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aberrant membranous pockets adjacent to the FV (Fig. 3b,
RAP, double black arrows and blue dotted line), indicating
a defect in daughter merozoite formation. Treatment of
mature schizonts with the cysteine protease inhibitor E64
traps separated merozoites within a membranous sac
[45, 46]. Giemsa staining (Fig. 3c) and TEM (Fig. 3d) on E64-
treated preparations of PfACT1 KO parasites unequivocally
demonstrated parasite organelles bounded within the
same membrane as the FV, strongly suggesting a merozo-
ite formation or cytokinesis defect. Interestingly, a similar
role of actin-1 in daughter cell formation has recently
been described for Toxoplasma [6], indicating conserved
function during this process, despite the two genera
replicating differently (schizogony and endodyogeny).
Fig. 3 PfACT1 is required for normal cytokinesis. a IFA of PfACT1 KO and control schizonts. Aberrant staining of the plasma membrane marker
MSP1 (red) depicts dysmorphic merozoites in the schizonts (white arrow) in the absence of PfACT1 (actin). Scale bar 5 μm. Normal, moderately
aberrant (m.a.), and severely aberrant (s.a.) MSP1 staining has been exemplified (white arrows) and quantified (right). N > 300, error bars represent
SD. b TEM on C1-treated mature schizonts stalled just prior to egress. Whilst medially resident daughter merozoites have distinct, separated
membranes apposed to the FV membrane in DMSO controls (black arrows), aberrant membranous pockets including merozoite material are
observed in RAP-treated parasites (double black arrows and outlined by blue dotted line). c Giemsa-stained, E64-treated mature schizonts show
conjoined merozoites (black arrows) with ~50% frequency in the RAP-treated sample as compared to <10% in DMSO controls. N > 300, scale bar
5 μm. Error bars represent SD. d TEM of E64-trapped merozoites. Merozoites in DMSO controls are distinct and well formed, with organelles not
included within the FV membrane (left panel). The RAP-treated population has FVs (black arrow) which include organelles normally resident in
daughter merozoites. Some merozoites show aberrant surface architecture (asterisked). Merozoites conjoined to each other are frequently seen in
the PfACT1 KO population (right panel). TEM scale bar 500 nm. Other scale bars 5 μm
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To avoid splenic clearance, P. falciparum-infected
erythrocytes adhere to host vasculature and withdraw
from circulation. Adherence is mediated by protrusions
called knobs on the infected-erythrocyte surface which
contain host cytoskeletal components and parasite-
derived proteins [47]. Export of proteins requires traf-
ficking across the parasite plasma membrane and the
PV membrane and is thought to be mediated via mem-
branous structures called Maurer’s clefts resident
within the host erythrocyte cytoplasm [48]. To assess
whether loss of PfACT1 impacts Maurer’s cleft forma-
tion, we performed TEM on PfACT1 KO trophozoites
and schizonts. RAP-treated parasites were indistin-
guishable from DMSO controls in their ability to form
Maurer’s clefts in the host cytoplasm, suggesting that
this process does not rely on parasite actin to proceed
(Additional file 5: Figure S5).
PfACT1 KO merozoites are capable of egress but remain
connected to the central FV
Egress from the mature schizont is a well-orchestrated
and tightly regulated process in P. falciparum develop-
ment, enabling daughter merozoites to be released in
the blood stream to start a new round of invasion and
intraerythrocytic growth. When a mature schizont is
ready for egress, a key effector serine protease,
subtilisin-like protease 1 (SUB1) [49], is released into the
PV space in a regulated manner from specialised
microneme-like organelles called ‘exonemes’. This is
followed by the disruption of the PV membrane and
finally the dissemination of daughter merozoites [45].
Actin plays a fundamental role in regulated exocytosis in
mammalian cells [50]; it is therefore conceivable that an
actin-dependent process may function at the heart of
egress, either for secretion of SUB1-containing exonemes
or for enabling rapid merozoite movement observed just
before host cell rupture [25], especially given that deple-
tion of actin-1 in Toxoplasma led to a complete block in
host cell egress [7].
The reversible protein kinase G inhibitor C1 [51] stalls
schizonts at a mature stage of development by blocking
the secretion of SUB1. Washing away C1 allows the
natural release of merozoites within minutes [45]. We
performed time lapse video microscopy of C1-stalled
purified PfACT1 KO schizonts to test their ability to
complete the asexual cycle and undergo egress. On
washing away C1, PfACT1 KO schizonts underwent
egress in explosive events similar to the DMSO controls
(Additional file 6: Video S1 and Fig. 4a), indicating an
actin-independent mechanism of exoneme secretion and
egress. However, recapitulating the earlier observed
defects in optimal merozoite formation (Fig. 3), a large
proportion of the released PfACT1-disrupted merozoites
could not separate from each other (Additional file 6:
Video S1, RAP, white arrows, and Fig. 4a). In agreement
to this, parasite-derived structures in close apposition to
the central FV were observed in Giemsa-stained
PfACT1 KO populations (Fig. 4b). Scanning electron
microscopy (SEM) on the PfACT1 KO population post-
egress further showed clusters of conjoined merozoites
connected to each other and to the central FV (Fig. 4c),
indicating a failure to efficiently separate in the final
stages of cytokinesis. On performing an IFA with a
merozoite surface marker and a microneme marker, it
appeared that these clusters were connected by the
parasite plasma membrane and contained nuclei as well
as micronemes (Fig. 4d), strongly indicating a partial
cytokinesis defect in PfACT1 KO schizonts, as
discussed in the previous section.
Despite the presence of non-separated clusters of mer-
ozoites, several individual free merozoites were released
upon egress in the PfACT1 KO population (Additional
file 6: Video S1; Fig. 4a, b, and e). When SEM was
performed on these merozoites, we found that, similar
to the situation in T. gondii, the membrane in PfACT1
KO parasites appeared uneven and ruffled compared to
the normally smooth appearance of control parasites
(Fig. 4e).
Loss of PfACT1 leads to a complete abrogation of
invasion, despite merozoites retaining the ability to
secrete micronemes
We next tested the ability of PfACT1 KO parasites to in-
vade erythrocytes. Two independent clones B2 and F4
showed complete abrogation of invasion upon PfACT1
disruption (Fig. 5a). Since PfACT1 KO parasites are
defective in merozoite separation (Fig. 4 and Additional
file 6: Video S1), we added a control where the experiment
was performed with vigorous shaking of the culture flasks
in an attempt to separate any loosely attached merozoites.
Despite this, in contrast to controls, the RAP-treated
parasites could not invade erythrocytes (Fig. 5a).
Invasion is a multistep process, involving the regulated
release of micronemes and rhoptries. Consequently, a
blockade in either process could lead to a defect in inva-
sion, and indeed P. falciparum actin has been implicated
in regulated secretion [12]. We tested the capability of
PfACT1 KO parasites to secrete their microneme
contents. Super-resolution microscopy revealed that
PfACT1 KO parasites retained their ability to secrete the
microneme protein AMA1 onto the surface (Fig. 5b).
AMA1 is shed from the free merozoite surface by se-
creted and membrane-resident proteases prior to inva-
sion [20]. We reasoned that if AMA1 is secreted onto
the surface, processed AMA1 should be detectable in
culture supernatants. Consistent with this, we observed
processed AMA1 in the supernatants of egressed
PfACT1 KO schizonts by Western blot (Fig. 5c).
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Moreover, PfACT1 KO free merozoites which were not
conjoined displayed no defects in IMC morphology
(Additional file 7: Figure S6). Therefore, the abroga-
tion of invasion displayed by PfACT1 KO parasites
cannot be attributed to a block in microneme
secretion or due to structural inadequacy. In order to
qualitatively determine whether the observed lack of
invasion by PfACT1 KO parasites is due to the
inability of the parasites to attach to erythrocytes,
thin blood films were made at the end of the invasion
assay. Microscopic observation revealed that PfACT1
KO merozoites could attach to erythrocytes (Fig. 5d,
RAP, black arrow). This phenocopied cytochalasin-D-
treated control parasites, which could also attach to
erythrocytes but could not successfully invade them
(Fig. 5d, DMSO + CytD, black arrows).
Next, we assessed if attached PfACT1 KO merozoites
could form a circular tight junction (TJ), a prerequisite
for invasion [52, 53], using the junction markers AMA1
and rhoptry neck protein 4 (RON4) as described previ-
ously [54]. Seventy-six percent of DMSO control para-
sites invaded erythrocytes in the time frame of the assay
(Fig. 5e and f). In contrast, 84% of RAP-treated parasites
attached to the erythrocyte and could undergo reorienta-
tion and appeared to secrete RON proteins which are
required for formation of the junction. However, a
typical circular junction could never be observed and
parasites were incapable of invading erythrocytes,
Fig. 4 PfACT1 KO merozoites remain conjoined post-egress and possess a dysmorphic ruffled surface. a Still images from Additional file 6: Video S1
show normal explosive egress in PfACT1 KOs; however, the RAP-treated population displays conjoined merozoites attached to the FV (white arrows),
compared to completely segregated merozoites not attached to the FV (blue arrows) in DMSO controls. b Post-egress, Giemsa-stained RAP-treated
populations have parasite structures attached to the FV (black arrow). In DMSO controls, the newly released daughter merozoites are free and not
connected to the FV. Scale bar 5 μm. c Conjoined merozoites with a dysmorphic ruffled surface are apparent by SEM in the RAP-treated population.
Scale bar 5 μm. d IFA on post-egress preparations of RAP-treated parasites reveals nuclei (DAPI) and micronemes (AMA1) joined to the FV, with the entire
structure bounded by a contiguous plasma membrane (MSP1); defect observed in 76% of all FVs. The FV and merozoites are distinct in DMSO controls
(94% of all FVs). N= 21 for DMSO and N = 33 for RAP. Scale bar 5 μm. e Free merozoites are released in the PfACT1 KO population, though they often
possess a ruffled surface as observed by SEM. Scale bar 1 μm
Das et al. BMC Biology  (2017) 15:70 Page 8 of 16
demonstrating a critical requirement for parasite actin
for host cell invasion. This observation closely phe-
nocopied cytochalasin-D treatment of the control
population (Fig. 5f, DMSO + CytD). Finally, we tested
the potency of PfACT1 KO merozoites to deform eryth-
rocytes to which they attached. We performed video
microscopy of egressing schizonts in the presence of
erythrocytes (Additional file 8: Video S2) and scored the
Fig. 5 PfACT1 KO merozoites can secrete their micronemes and form a tight junction (TJ) but cannot invade erythrocytes. a No reinvasion is observed
for the RAP-treated population (+) in invasion assays with schizonts purified from two distinct clones B2 and F4. Even upon vigorous shaking, which
improved reinvasion rates of the DMSO controls (–), a complete abrogation of invasion was apparent in the RAP-treated population (*). N > 1000 in
each case. Error bars represent SD. b Super-resolution microscopy of free merozoites. Colocalisation of AMA1 and MSP1 on the surface of PfACT1 KO
(RAP) and control (DMSO) populations indicates that secretion of AMA1 is not ablated in the absence of PfACT1. Scale bar 500 nm. c A dual Western
blot with anti-AMA1 and anti-PfACT1 antibodies reveals that AMA1 is processed and shed in culture supernatants of the PfACT1 KO population (+),
indicating the ability of the PfACT1 KOs to secrete, process and shed AMA1. Note that some AMA1 remains unprocessed in the KOs, perhaps indicative
of dysregulation of secretion in a small population of the merozoites. As expected, PfACT1 is absent in the RAP-treated (+) population and is absent in
the culture supernatants, confirming integrity of the parasite membranes during the experiment. d Merozoites are attached to erythrocytes (arrowed)
in Giemsa-stained thin blood films from the PfACT1 KO population (RAP), which phenocopies cytochalasin-D treatment during invasion (DMSO+ CytD).
DMSO controls reinvade and form ring stages during the time frame of the experiment (DMSO). Scale bar 5 μm. e IFA of TJ formation. Colocalisation
of rhoptry neck protein 4 (RON4) and AMA1 at the merozoite-erythrocyte boundary indicates successful TJ formation in DMSO controls (upper two
panels), controls treated with cytochalasin D (middle two panels) and in PfACT1 KOs (lower two panels). The state of invasion of the merozoite is
depicted on the right of the panels (brightfield). Scale bar 5 μm. f Relative percentages of the state of invasion of merozoites in each of the cases is
drawn as a relative bar graph. Each merozoite counted was binned to one of the following groups: invaded, mid-invasion, reoriented, attached
(not reoriented) and unattached. The numbers counted have been indicated. Note that the PfACT1 KO (RAP) population closely phenocopies
the cytochalasin-D-treated population
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degree of erythrocyte deformation caused by free mero-
zoites as described previously [55]. In DMSO controls,
33% of attached merozoites caused mild deformation
(score = 1) and 39% caused severe deformation (score = 2
and 3). In contrast, PfACT1 KO merozoites only formed
sustained contacts (score = 0), with only one instance of
mild deformation observed (Additional file 8: Video S2
and Fig. 6a, b).
Based on these results, we conclude that PfACT1, in
contrast to Toxoplasma actin [7], is essential for host
cell invasion and that host cell membrane dynamics
cannot facilitate uptake of the merozoite in absence of
a functional acto-myosin system, as has been described
for T. gondii [30]. Any parasite in the RAP population
that invaded a host cell represented non-excised para-
sites as evidenced by IFA using an actin antibody (data
not shown). Such instances allowed us to confirm the
presence of filamentous actin close to the junction in
PfACT1-positive merozoites penetrating a host cell
(Additional file 9: Figure S7a), as described previously
[42]. Cytochalasin -D is known to have off-target ef-
fects when used in high concentrations in Toxoplasma
[29]. Since cytochalasin-D treatment closely pheno-
copies the invasion phenotypes observed for PfACT1
KO parasites, and in order to determine if the specific
target for the drug is indeed PfACT1, we used
CRISPR/Cas9 [56] to introduce a single point mutation
(Ala136 (GCT)→Gly136 (GGT)) into the pfact1 gen-
omic locus on an otherwise wild-type 3D7 background
(Additional file 9: Figure S7b). Mutation of this site in
Toxoplasma has previously been shown to confer
resistance to cytochalasin [19]. Analysis of three
independent cytochalasin-D-resistant mutant clones
(Additional file 9: Figure S7c) demonstrated that inva-
sion of erythrocytes was possible in the presence of
concentrations of cytochalasin-D where erythrocyte
invasion by wild-type parasites is inhibited [57]. This
indicates that PfACT1 is indeed the target for erythro-
cyte invasion inhibition following cytochalasin-D treat-
ment [57] and not an off-target host component.
However, higher cytochalasin-D concentrations led to
a blockade of invasion in cytochalasin-D-resistant
mutants, similar to the situation in T. gondii [29]. In
fact, cytochalasin-D-resistant mutants could be ob-
tained in T. gondii, where no mutation in actin could
be identified [19].
Discussion
In this study we analysed the role of PfACT1 during the
intraerythrocytic life cycle of P. falciparum and discov-
ered highly conserved as well as unique Plasmodium-
specific functions. Upon induction of DiCre-mediated
excision of pfact1 in 1-h-old ring stages, protein levels of
PfACT1 dropped considerably between 24 and 34 h,
reaching <7% at 44 h as observed by Western blot
(Additional file 1: Figure S1b). Therefore, whilst we have
strong evidence for PfACT1 KO phenotypes in late
trophozoites, schizonts stages and during invasion, we
cannot rule out essential functions of PfACT1 in earlier
stages of development, especially in ring stages. Never-
theless, loss of PfACT1 occurred within 40 h in ~98% of
RAP-treated parasites (Additional file 2: Figure S2),
enabling us to dissect protein function robustly on a
population level.
As expected, PfACT1 is essential for parasite viability,
and its disruption caused parasite death within one
developmental cycle, with phenotypes manifesting at the
segmented schizont stage. First, without PfACT1, the
apicoplast collapsed and an amorphous mass accumu-
lated close to the FV (Fig. 2, Additional file 2: Figure
S2). Although Toxoplasma actin is also required for
apicoplast maintenance [7], the phenotype is not as
drastic as that of P. falciparum. We speculate that this
difference is due to differences in the mechanism of
parasite replication and segregation during endodyogeny
(Toxoplasma) versus schizogony (Plasmodium) and not
due to differences in actin function during apicoplast
segregation. Intriguingly, individual apicoplasts appear to
be connected via filamentous F-actin, as seen in colocali-
sation analysis using antibodies preferentially recognis-
ing F-actin. We speculate that apicoplast replication
and inheritance are aided by movement of the apico-
plast, potentially along dynamic F-actin structures
Fig. 6 PfACT1 KO merozoites make sustained contacts with
erythrocytes but are deficient in their ability to deform them. a Still
images from time lapse videos showing examples of various degrees
of erythrocyte deformation (scored from 0 to 3) caused by merozoites.
b Quantification of erythrocyte deformation scores of DMSO control
and RAP-treated parasites. Numbers counted are depicted below
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(Fig. 7). In good agreement, whilst the repertoire of
myosins in different apicomplexans is diverse [5],
MyoF, which has been demonstrated to be required
for apicoplast segregation in Toxoplasma [58], is con-
served in these parasites, suggesting a highly con-
served mechanism.
During schizogony, a defect in merozoite formation/
cytokinesis was evident in PfACT1 KOs, especially in
medially resident nascent merozoites close to the FV
(Fig. 3). Consistent with this, a large proportion of
egressed merozoites remained connected to each other
in structures resembling bunches of grapes, which con-
tained nuclei as well as apical organelles (Fig. 4). These
observations are similar to defects observed in Toxo-
plasma daughter cell formation, which were described
as ‘defects in formation of the inner membrane complex’
[6]. The defects in cytokinesis observed are also similar
to findings of a recent report where the authors knocked
down P. falciparum merozoite organising protein
(PfMOP) and observed agglomerates of merozoites due
to flawed segmentation [59]. Actin-1 in the ciliate
Tetrahymena thermophila, which is closely related to
the apicomplexans, is required for the final stages of
cytokinesis during which the daughter cells twist and
separate from each other [60]. Specifically, this process
was compromised in an actin-1 knockout, and the cells
displayed retraction of the division furrow [60]. We hy-
pothesise that actin-1 may be involved in cell separation
during the final stages of cell division in P. falciparum
(and in Toxoplasma) in a similar manner to that in Tet-
rahymena (Fig. 7). In the absence of PfACT1, we specu-
late that merozoites failed to separate in the very final
stages of cytokinesis followed by various degrees of re-
traction of the cleavage furrow, giving rise to a different
number of merozoites conglomerated around the FV in
different schizonts.
Whilst the essential roles of actin during apicoplast
segregation and daughter cell separation appear to be
highly conserved in apicomplexan parasites, we noted
significant differences in actin function in several aspects
of parasite development between Toxoplasma and Plas-
modium. Of special interest is the role of actin during
host cell egress and invasion. Contrary to our expecta-
tions, it appears that egress itself does not require
PfACT1 per se; data presented in this work (Additional
file 6: Video S1) prove that egress in P. falciparum does
not depend on parasite actin. Consistent with this, treat-
ment of schizonts with cytochalasin-D did not prevent
egress of P. falciparum schizonts, but completely
blocked invasion (Sujaan Das and Michael J Blackman,
unpublished, and also evident in Video S8 of another re-
port [55]). Some released PfACT1 KO merozoites were
morphologically aberrant, and this is attributable to the
defects in cytokinesis discussed above. The force re-
quired for egress possibly comes from osmotic swelling
and outward curling of the host cell membrane [61] and
does not require the function of an acto-myosin motor.
In contrast, Toxoplasma egress is critically dependent on
actin function [7].
In a recent study, Toxoplasma parasites were shown to
be capable of moving and invading the host cell upon
deletion of critical components of the acto-myosin
system, including the single-copy actin gene [7], demon-
strating that T. gondii can employ alternative mecha-
nisms for motility and host cell invasion. Indeed it
appears that host cells are capable of taking up genetic-
ally impaired mutants in a process similar to macropino-
cytosis [30]. However, based on our results, we can rule
out erythrocyte-driven uptake of merozoites as the driv-
ing force during invasion, since PfACT1 KO parasites
show a complete ablation of entry, demonstrating
PfACT1’s essential role in the process.
Conclusions
In summary, our study demonstrates functional conser-
vation and differences between Toxoplasma and Plasmo-
dium actin, and we would expect additional differences
in function of other core factors of the gliding and
Fig. 7 A model visualising the intracellular functions of PfACT1
during P. falciparum asexual stages (upper panels) and the
corresponding phenotypes when PfACT1 function is disrupted
(lower panels). 1. Apicoplast (green) migration requires the presence
of PfACT1 filaments (grey dotted lines, upper panel), failing which
they collapse around the FV (lower panel). 2. PfACT1 is required to
separate daughter cells in the final stages of cytokinesis (upper
panel). In the absence of PfACT1, conglomerates of merozoites are
observed, indicating a role for actin in normal daughter merozoite
formation (lower panel). 3. Invasion of the host erythrocyte requires
the presence of PfACT1 in released daughter merozoites (upper
panel). In the absence of PfACT1, the merozoite attaches, reorients
but is abrogated in its ability to invade the host cell (lower panel)
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invasion machinery. Therefore, whilst cross-comparison
between these two species has certainly guided under-
standing, future comparative studies will be important
for defining conserved versus evolutionary niche-specific
adaptations of the core molecules required for motility
and host cell invasion. Mechanistic dissection of PfACT1
involvement in P. falciparum development is not only of
biological interest, but owing to the divergence of para-
site actin from mammalian actins, can realistically form
the basis for development of therapeutics targeting its
function towards specific intervention against apicom-
plexan diseases [62].
Methods
Culture and transfection of P. falciparum
P. falciparum was cultured in RPMI 1640 with Albumax®
(Invitrogen), and schizonts were purified on a bed of 70%
Percoll® as described previously [63]. About 10 μg of plas-
mid was ethanol precipitated and resuspended in 10 μL
sterile buffer Tris-ethylenediaminetetraacetic acid (EDTA)
(Qiagen, Hilden, Germany). The Amaxa™ P3 primary cell
4D-Nucleofector™ X Kit L (Lonza, Cologne, Germany)
was used for transfections. The input DNA was added to
100 μL P3 primary cell solution, mixed with 10–20 μL of
packed synchronous mature schizonts and added to the
cuvette, which was electroporated in a 4D-Nucleofector
machine (Lonza) using the program FP158. The trans-
fected schizonts were rapidly added to 2 mL of complete
medium (RPMI with Albumax supplemented with glu-
tamine) containing erythrocytes at a haematocrit of 15%,
and left shaking in a shaking incubator at 37 °C for
30 min. Finally the cultures were supplemented with 7 mL
of complete RPMI medium to obtain a final haematocrit
of 3% and incubated overnight at 37 °C in a small angle-
necked flask (Nunc™). The presence of the human
dihydrofolate reductase (hdhfr) selectable marker in the
transfection plasmids allowed selection of integrants
with the antifolate WR99210 (Jacobus Pharmaceutical
Company, Princeton, NJ, USA), added to 2.5 nM 20 h
after transfection. The culture medium was subsequently
exchanged every day for the next 4 days to remove cell
debris which accumulates during electroporation and then
twice a week until parasites were detected by Giemsa
smear. Drug-resistant parasites were generally detectable
in thin blood films 2–3 weeks post-transfection. After this,
parasite stocks (at ~5% ring parasitaemia) were cryo-
preserved in liquid nitrogen, and genomic DNA was
prepared for parasites containing integration vectors.
Integrants were selected by drug cycling as follows. Drug
was removed from the medium and parasites cultured in
its absence for 3–4 weeks, after which the drug was added
back and the medium changed daily for 2 days. Once
parasitaemia was re-established, parasites were cryopre-
served in liquid nitrogen, and genomic DNA was prepared
using a Qiagen Blood and Tissue kit. The above cycling
process was repeated until integration was detectable by
PCR analysis. Integration was confirmed by diagnostic
PCR using primers UOT_pfact1 _FOR and syn_pfact1_REV.
Integrant lines were then cloned by limiting dilution using a
simple plaque assay [64], and two clones, B2 and F4, were
used for phenotypic characterisation.
Conditional excision of the pfact1 locus
Conditional recombination between loxP sites was
performed as previously described [39]. Briefly, 1-h-old
newly invaded ring stages were purified and divided into
two flasks. The pfact1 locus was disrupted by condi-
tional activation of DiCre with a 4-h pulse treatment
with 100 nM RAP. The control flask was treated with
DMSO for 4 h. The parasites were then washed and
returned to culture. Diagnostic PCR was performed at
various time points after addition of RAP (18, 34 and
44 h). The intact modified locus was amplified using
primers UOT_pfact1_FOR and syn_pfact1_REV (Fig. 1b
‘Int’ and Additional file 10: Table S1), the ‘excised’ locus
using primers pfact1_FOR2 and pfact1REV4 (Fig. 1b
‘Exc’ and Additional file 10: Table S1) and the control
locus using primers pfact1_FOR1 and pfact1_REV3
(Fig. 1b ‘Con’ and Additional file 10: Table S1). Protein
levels were monitored by Western blot as follows. At
each time point samples were drawn and erythrocyte
membranes disrupted with 0.1% saponin in phosphate-
buffered saline (PBS) followed by washes in the same
buffer. Parasite protein was subsequently extracted in
SDS gel loading buffer supplemented with 100 mM di-
thiothreitol and boiled for 10 min. We ran 12% poly-
acrylamide gels, and the proteins were transferred onto
a nitrocellulose membrane prior to immunoblotting.
Proteins were visualised using the LiCOR Odyssey® im-
aging system (LiCOR Biosciences, Frankfurt, Germany).
Growth (Fig. 1e) was determined by microscopic
counting of parasites from Giemsa-stained thin blood
films. On day 2, both the RAP-treated culture and the
DMSO control culture were diluted 10× to avoid over-
growth of parasites. Parasitaemia values multiplied by
the dilution factor have been presented on the graph
(Fig. 1e). At least 1000 erythrocytes were counted at
each time point in three independent counts, and the
mean parasitaemia values were plotted with standard
deviation (SD) as error bars.
IFA
Thin blood films were made on glass slides and fixed in
4% paraformaldehyde in PBS for 20 min. The slides were
then permeabilised with 0.1% Triton-X/PBS for 10 min,
washed and blocked overnight in 4% bovine serum
albumin (BSA)/PBS. Antigens were labelled with suitable
primary (for a list of antibodies used in this study please
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see Additional file 12: Table S3) and secondary anti-
bodies in 4% BSA/PBS with 5-min PBS washes in
between. Slides were finally air dried and mounted with
4’6-diamidino-2-phenylindole (DAPI)-Fluormount-G® (South-
ernBiotech, Birmingham, AL, USA).
Staining of the AMA1/RON4 junction in the PfACT1
KOs was performed by fixation and immunostaining in
solution as described previously [54]. Along with the
comparison of PfACT1 KOs with the DMSO controls,
cytochalasin-D treatment of the DMSO population was
done at a final concentration of 1 μM. Formation of the
junction was quantified as follows. Every parasite was
binned in one of the following groups: unattached,
attached (not reoriented), reoriented (junction formed),
mid-invasion and invaded. Relative percentages of each
of the groups were presented in a bar graph.
For image acquisition, z-stacks were collected using a
UPLSAPO 100× oil (1.40NA) objective on a Deltavi-
sion Core microscope (Image Solutions — Applied
Precision, GE) attached to a CoolSNAP HQ2 CCD
camera. Deconvolution was performed using SoftWoRx
Suite 2.0 (Applied Precision, GE).
An Elyra S1 microscope with Superresolution Structured
Illumination (SR-SIM) (Zeiss) was used for super-resolution
dissection of AMA1 staining on the merozoite surface and
for apicoplast colocalisation with actin filaments.
Electron microscopy
Samples were fixed in 2.5% glutaraldehyde and 4% parafor-
maldehyde in 0.1 M phosphate buffer, pH 7.2, for electron
microscopy analysis. For TEM, the samples were washed
in 0.1 M phosphate buffer, pH 7.2 and post-fixed in 1%
OsO4 for 1 h on ice. After several washes in the same
buffer, the samples were en bloc stained with 0.5% uranyl
acetate in water for 30 min. Samples were then washed
with water, dehydrated in ascending acetone series and
resin embedded. Ultrathin sections were collected and
imaged on a Tecnai T20 Transmission electron micro-
scope (FEI, Eindhoven, Netherlands).
For SEM, the fixed samples were allowed to adhere on
poly-L-lysine-coated coverslips for 20 min, followed by
several washes with 0.1 M phosphate buffer. The samples
were dehydrated in ascending ethanol series and critical
point dried (Tousimis Research, Rockville, MD, USA).
The coverslips were mounted on stubs and sputter coated
with a 10-nm layer of gold/palladium (Quorum, Laughton,
UK) and imaged on a Jeol 6400 scanning electron micro-
scope (Jeol, Tokyo, Japan). All images obtained were
analysed and processed with Fiji software [65].
Time lapse video microscopy of P. falciparum parasites
Video microscopy of P. falciparum schizont egress was
performed as described previously [45]. Synchronised
schizonts were Percoll-purified and treated with 2 μM
C1 in RPMI medium with Albumax (Gibco) for 4 h.
Microscopy chambers (internal volume ~80 μL) for
observing live schizonts were constructed by adhering 22 ×
64 mm borosilicate glass coverslips to microscope slides
with strips of double-sided tape, leaving ~4 mm gaps at
each end. C1 was washed off before video microscopy, and
the schizonts were immediately resuspended into warm
(37 °C) RPMI (with Albumax) and introduced by capillary
action into the pre-warmed chamber. The chamber was
transferred to a temperature-controlled microscope stage at
37 °C on a Deltavision Core microscope (Image Solutions
— Applied Precision, GE). Images were routinely collected
at 5-s intervals, beginning 6 min 30 s after washing
off C1, over a total of 30 min.
Time lapse video microscopy of erythrocyte invasion by
merozoites was performed as described previously [55]
with certain modifications. Briefly, synchronised mature
schizonts were Percoll-purified and further allowed to ma-
ture for 4 h in 2 μM C1. C1 was then washed off, and the
schizonts were added to an erythrocyte suspension (0.4%
haematocrit) in RPMI medium at 37 °C before transferring
to the above-described microscopy chambers. Images
were taken every second on a Deltavision Core micro-
scope (Image Solutions — Applied Precision, GE) using a
heated stage maintained at 37 °C and 5% CO2. Import-
antly, low light and exposure conditions were maintained
to avoid phototoxicity to invading merozoites. Erythrocyte
deformation by merozoites was scored as described previ-
ously [55] on a scale of 0 to 3 and plotted on a graph. A
stringent condition of sustained contact of >1 s was used.
Invasion and AMA1 shedding assays
Equal numbers of Percoll-purified schizonts from DMSO
and RAP-treated cultures were resuspended in RPMI
(+Albumax) containing 1% haematocrit blood (volume
4 mL) to a final parasitaemia of ~1–2%. These cultures
were further split into two and incubated at 37 °C with or
without vigorous shaking for 1 h. Parasitaemia values of
newly invaded ring forms were counted by microscopy of
Giemsa-stained thin blood films after overnight incubation.
For AMA1 shedding assays, Percoll-purified schizonts
from DMSO- and RAP-treated cultures were cultured for
an additional 4 h in 2 μM C1 to ensure complete matur-
ation of segmented schizonts. C1 was washed away and the
schizonts resuspended in RPMI (without Albumax) and
incubated for 30 min at 37 °C. The culture supernatant was
separated from the pellet by centrifugation at 13,000 rpm
in a benchtop centrifuge. Pellets and supernatants were de-
natured using reducing SDS sample buffer and used for
Western blot using anti-AMA1 and anti-actin antibodies.
Design of pL7-pfact1AdG
A gene fragment consisting of a recodonised region of
the PfACT1 coding sequence (including the C - > G
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point mutation) and flanked by NT and CT homology
regions was synthesised by GeneART and cloned into
the pL6-eGFP CRISPR plasmid [56]. The pL6-eGFP
plasmid was linearised for cloning using SacII/AflII
restriction sites. The guide DNA sequence (ATC
CAAAAGGAAATCGTGAG) was cloned into the same
plasmid using the BtgZI adaptor site [56], producing
the completed pL7-pfact1AdG plasmid. All cloning
steps were performed using Gibson assembly [66].
Invasion assays with cytochalasin-D-resistant mutants
P. falciparum schizont stage parasites were diluted to
produce a suspension of 2% haematocrit and 2% parasit-
aemia in media containing increasing concentrations of
cytochalasin D (from 0 μM to 0.8 μM). A 10-μL aliquot of
the parasite suspension was fixed in 2% paraformaldehyde/
0.2% glutaraldehyde/PBS for 45 min at 4 °C. The fixed cells
were kept in 50 μL PBS until further use. The remaining
parasite suspension was added into a 96-well round-
bottomed plate at 100 μL volume per well. After 24 h
incubation under standard culture conditions, a 10-μL
aliquot of the ring stage parasite suspension was removed
from each well and fixed as above. Fixed cells from both
days were permeabilised in 0.3% Triton X-100/PBS for
10 min at room temperature and stained with SYBR
Green I (Life Technologies)/PBS (1:5000) for 45 min at
room temperature in the dark. This was followed by
acquisition on a flow cytometer (50,000 events), and
parasitaemia was determined by SYBR Green I fluores-
cence as measured by the flow cytometer. All experiments
were carried out in triplicate, and the data are presented
as mean ± SD and normalised to the mean parasitaemia of
each strain in 0 μM cytochalasin D.
Additional files
Additional file 1: Figure S1. The phenotypic effect of PfACT1
disruption at various time points in the 48-h development cycle. (a)
Giemsa-stained thin blood films showing the effect of RAP treatment at
various points in the replication cycle. Highly synchronous 1-h-old freshly
invaded ring stages were pulse-treated for 4 h with 100 nM rapamycin
(RAP at 1 h) or DMSO, washed and returned to culture. Thin blood films
were prepared at various time points and Giemsa stained. No phenotype was
apparent in the trophozoite stages (26 h, 38 h RAP at 1 h) as compared to
DMSO controls, but a complete blockade in invasion was observed in the
same replication cycle (48 h, RAP). When RAP treatment was performed at
30 h post-invasion (RAP at 30 h) for 4 h, the phenotypic blockade of invasion
was still observed in the same cycle at 48 h. However, when RAP treatment
was performed at 44 h post-invasion (RAP at 44 h), invasion occurred
normally in the same replication cycle and the phenotypic blockade occurred
during invasion in the next replication cycle (48 h, next cycle). Scale bars
5 μm. (b) Left panel: Western blot showing a time course of loss of PfACT1
(green) upon RAP treatment of 1-h-old ring stages, with samples drawn at 24,
34 and 44 h post-induction. Anti-aldolase antibody (red) was used as loading
control. Right panel: Fluorescence intensity of PfACT1 in DMSO controls and
RAP-treated population normalised to the intensity of aldolase plotted as a
function of time post-RAP treatment. Note that PfACT1 levels in DMSO
controls increase about threefold from 34 h to 44 h. (JPEG 2570 kb)
Additional file 2: Figure S2. RAP treatment causes loss of PfACT1 in
~98% of the population together with an apicoplast segregation defect.
IFA of parasites harvested at mature schizont stages 44 h post-RAP treatment
and further incubated in C1 for 4 h showed loss of PfACT1 in ~98% of
the population. A field with one non-excised parasite was deliberately
chosen to highlight the specificity of the anti-PfACT1 antibody. Every
schizont non-reactive to anti-PfACT1 possessed a collapsed mass of
apicoplast(s) evident in the ‘merge’ panel. (JPEG 1290 kb)
Additional file 3: Figure S3. Committed gametocytes persist in culture
44 h post-disruption of PfACT1. IFA showing staining of parasites with the
gametocyte-specific marker Pfs16. The frequencies of Pfs16-positive parasites
in the DMSO controls and in RAP-treated parasites were normalised to the
number of schizonts present, and found to be not significantly different
from each other (percentages depicted below panel, error intervals repre-
sent SD), indicating that sexually committed gametocytes persist 44 h after
RAP treatment. Scale bar 5 μm. (JPEG 232 kb)
Additional file 4: Figure S4. IMC formation is aberrant in PfACT1 KO
parasites. Upper panels: IFA showing GAP45 staining of mature schizonts
in DMSO controls or PfACT1 KO population. PfACT1 KO parasites display
a disorganised GAP45 staining (red), indicating aberrant IMC formation in
schizonts. Scale bar 5 μm. Lower panel: Quantification of GAP45 staining
reveals aberrant IMC formation in ~50–60% of the PfACT1 KO population,
N > 150. Error bars represent SD. (JPEG 473 kb)
Additional file 5: Figure S5. Maurer’s cleft formation is not compromised
in PfACT1 KO parasites. Representative images of membranous inclusions
typical of Maurer’s clefts (boxed: 1, 2) are presented. Maurer’s clefts were
observed in late trophozoites and schizonts of RAP-treated parasites (lower
two panels) in 34 of 37 micrographs, and are similar in architecture to DMSO
controls (upper panel), where they were observed in 25 of 27 micrographs.
Boxed regions are presented as larger panels on the right. Scale bar 500 nm.
(JPEG 2.10 kb)
Additional file 6: Video S1. PfACT1 is not required for parasite egress
from the host erythrocyte. Time lapse video microscopy of DMSO
controls (left panel) and RAP-treated PfACT1 KO parasites shows similar
mechanics of egress characterised by osmotic burst of merozoites. Unlike
the DMSO controls, merozoites connected to the FV and unable to de-
tach are visible in the RAP population (white arrows). Relative time shown
in minutes, scale bar 10 μm. (MP4 4392 kb)
Additional file 7: Figure S6. Released PfACT1 KO merozoites which
are not conjoined do not display any apparent structural defects in the
IMC. Representative IFA showing normal IMC staining observed with an
anti-MTIP antibody (red) in PfACT1 KO parasites. PfACT1 staining is in green.
Scale bar 1 μm. (JPEG 129 kb)
Additional file 8: Video S2. PfACT1 KO merozoites can attach to
erythrocytes but are incompetent in their ability to deform them. Time
lapse video microscopy of merozoites egressing from schizonts in the
DMSO control population shows significant deformation of erythrocytes
(top panels, blue arrows), whereas merozoites in the RAP population
attach to erythrocytes, but are lacking in their ability to deform them
(lower panels, white arrows). Relative time shown in minutes, scale bar
5 μm. (MP4 10682 kb) (MP4 10682 kb)
Additional file 9: Figure S7. Targeted mutation of PfACT1 to confer
cytochalasin D resistance demonstrates that drug-treated invasion arrest is
specific for PfACT1 and not an alternative host factor. (a) PfACT1 (green) stains
the site of junction formation (as marked by RON4) during merozoite invasion
of the red blood cell. Two merozoites are shown, one in which PfACT1 has
been deleted versus a second where PfACT1 is still present. Scale bar 5 μm.
(b) Genetic strategy for conferring cytochalasin D resistance to the pfact gene
and PCR confirmation of integration. (c) Growth curves of three mutant
clones positive for the Ala136 (GCT)→Gly136 (GGT) change, demonstrating
that they confer resistance to cytochalasin D compared to a wild-type control.
N= 50,000. Error bars represent SD. (JPEG 786 kb)
Additional file 10: Table S1. DNA oligonucleotides used in this study.
(DOC 29 kb)
Additional file 11: Table S2. Values for Figure S1b. (XLSX 11 kb)
Additional file 12: Table S3. Antibodies used in this study.
(DOC 58 kb)
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